MOSCOW (Reuters) - Kazakhstan has started production of Russia’s Sputnik V vaccine against the coronavirus, Russia’s RDIF sovereign wealth fund said on Monday.
Kazakhstan’s Karaganda pharmaceutical complex produced a “validation batch” of the vaccine on Monday that will be sent for checks at Russia’s Gamaleya Institute where Sputnik V was developed, RDIF said in a statement.
Reporting by Andrew Osborn, Anastasia Teterevleva; writing by Tom Balmforth; editing by Jason Neely
Our Standards: The Thomson Reuters Trust Principles.